Rigel Pharmaceuticals reported $49.67M in Equity Capital and Reserves for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acceleron Pharma XLRN:US $ 718.15M 44.88M
Acura Pharmaceuticals ACUR:US 382K 6.52M
Alexion Pharmaceuticals ALXN:US $ 12416.8M 765.6M
Amgen AMGN:US $ 8217M 30M
Anika Therapeutics ANIK:US $ 290.06M 3.26M
Applied Genetic Technologies AGTC:US $ 69.53M 16.28M
Arrowhead Research ARWR:US $ 408.82M 28.07M
Astrazeneca AZN:US $ 39744M 24068M
AstraZeneca AZN:LN 39744M 24068M
Biomarin Pharmaceutical BMRN:US $ 4266.15M 24.58M
Bristol Myers Squibb BMY:US $ 37213M 405M
Celldex Therapeutics CLDX:US $ 436.71M 254.43M
Chemocentryx CCXI:US $ 315.89M 14.38M
Daiichi Sankyo 4568:JP Y 1312228M 32130M
Dicerna Pharmaceuticals DRNA:US $ 107.66M 3.41M
Eli Lilly And LLY:US $ 7757M 1312.6M
Flexion Therapeutics FLXN:US $ -82377000 26.21M
Halozyme Therapeutics HALO:US $ 281.67M 161.93M
Heron Therapeutics HRTX:US $ 118.84M 41.27M
Immunogen IMGN:US $ 77.09M 8.63M
Intrexon XON:US $ 131.25M 27.95M
IONIS PHARMACEUT IONS:US $ 531M 51.67M
Karyopharm Therapeutics KPTI:US $ -125977000 42.84M
Ligand Pharmaceuticals LGND:US $ 812.07M 25.55M
Macrogenics MGNX:US $ 291.44M 27.61M
Neurocrine Biosciences NBIX:US $ 1346M 66.8M
Regeneron Pharmaceuticals REGN:US $ 17258M 2130.7M
Rigel Pharmaceuticals RIGL:US $ 49.67M 18.44M
Sangamo Biosciences SGMO:US $ 406.02M 39.44M
Ultragenyx Pharmaceutical RARE:US $ 933.67M 38.5M
Veracyte VCYT:US $ 1107.08M 135.9M